Molecular Pathology Laboratory Network, Inc. (MPLN) was presented with the Innovator Award on April 25, at the 2008 Pinnacle Business Awards hosted by the Knoxville Chamber.
“MPLN strives every day to deliver the most innovative diagnostic tools to improve the health of our community. So, it’s an honor to be recognized for our innovations by business leaders and peers,” said Roger Hubbard, PhD, founder, president and chief executive officer of MPLN.
The 2008 Pinnacle Awards honored nine Knoxville businesses and individuals for excellence in their fields and in the community. The Innovator Award is given to a business that has developed a new technology, innovative product or service or applied a business system or service in an innovative way.
“Like all the businesses nominated in every category, MPLN is in pursuit of excellence,” Hubbard said. “For us, that means being at the forefront of laboratory medicine with the most innovative molecular, cellular and clinical diagnostics, as well as novel research and development and clinical trial services.”
The Pinnacle Awards gala, held at the Knoxville Convention Center, was attended by more than 650 people. In 2007, MPLN received the Business Excellence Award in the mid-size category and was among the three finalists for the Innovator Award.
“Winning two Pinnacle Awards in a row is a great accomplishment that I am very proud to say we have earned,” said Hubbard. “MPLN is looking forward to even more exciting milestones in the future and appreciate the support and recognition the medical and business communities have given to us for our innovative success.”
MPLN is a privately-held molecular diagnostic laboratory founded in 1989 and headquartered in Maryville, Tenn. A leader in laboratory medicine, MPLN offers a comprehensive selection of molecular diagnostics and cytogenetic testing that targets oncology, obstetrics, gynecology, medical genetics, infectious disease and gastroenterology. The laboratory also has an active research and development and clinical trials comapny and has extensive expertise in chromosome analysis, flow cytometry, fluorescence in situ hybridization (FISH), real-time quantitative polymerase chain reaction technologies, immunohistochemistry and gene sequencing.
MPLN is certified by the Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of Tennessee, Florida, New York and Maryland.
For more information about our services, call MPLN at 865-380-9746 or 800-932-2943.
